From his blog...
.....
Fenbendazole is a decades old “off patent” formulation, meaning it is a generic that anyone can make and sell. But it is unique in that:
(i) it has already gone through human clinical trials (decades ago) as an anthelmentic (de-wormer), meaning all of the clinical trial work related to toxicity have already been done and it has, for many years, been deemed “safe for human consumption.
(ii) It’s original clinical approval was for intestinal parasites and not cancer.
(iii) In order to repurpose the drug as an anti-cancer protocol would require all new and very expensive clinical trials.
(iv) No company is going to spend millions of dollars in the required regulatory work to repurpose the drug for cancer WITHOUT any proprietary protection from competition. It would be suicidal to do the heavy lifting in approval costs, only to have a generic manufacturer ride those coattails and compete the next day (And the synthesis of the fenbendazole molecule is very easy and cheap to do)
Screw the clinical trials. If that time comes, I’m sure my wife will try it on the QT.
We saw her oncologist last week. Her cancer marker is climbing. The oncologist asked what she wanted to do after declining Verzenio (due to cost and reported side effects).
I lied and said fasting and prayer.
She starts Hyperbaric Oxygen Therapy next week. :)